vs
ARTIVION, INC.（AORT）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
ARTIVION, INC.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.6倍（$116.0M vs $70.9M），ARTIVION, INC.净利率更高（2.1% vs -7.8%，领先9.8%），ARTIVION, INC.同比增速更快（19.2% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-7.9M），过去两年ARTIVION, INC.的营收复合增速更高（9.1% vs -2.0%）
Artivion, Inc.是一家专注于心血管移植领域的医疗企业，主要供应经深低温冷冻保存的人体组织，同时研发各类医疗器械。旗下核心产品包括经过特殊处理、去除多余细胞物质与抗原的人体心脏瓣膜，以及BioGlue手术粘合剂，可为临床诊疗提供专业支持。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
AORT vs RICK — 直观对比
营收规模更大
AORT
是对方的1.6倍
$70.9M
营收增速更快
AORT
高出22.3%
-3.1%
净利率更高
AORT
高出9.8%
-7.8%
自由现金流更多
RICK
多$19.4M
$-7.9M
两年增速更快
AORT
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.0M | $70.9M |
| 净利润 | $2.4M | $-5.5M |
| 毛利率 | 63.1% | — |
| 营业利润率 | 9.2% | -0.7% |
| 净利率 | 2.1% | -7.8% |
| 营收同比 | 19.2% | -3.1% |
| 净利润同比 | 114.7% | -2354.9% |
| 每股收益（稀释后） | $0.06 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AORTRICK
| Q4 25 | $116.0M | — | ||
| Q3 25 | $113.4M | $70.9M | ||
| Q2 25 | $113.0M | $71.1M | ||
| Q1 25 | $99.0M | $65.9M | ||
| Q4 24 | $97.3M | $71.5M | ||
| Q3 24 | $95.8M | $73.2M | ||
| Q2 24 | $98.0M | $76.2M | ||
| Q1 24 | $97.4M | $72.3M |
净利润AORTRICK
| Q4 25 | $2.4M | — | ||
| Q3 25 | $6.5M | $-5.5M | ||
| Q2 25 | $1.3M | $4.1M | ||
| Q1 25 | $-505.0K | $3.2M | ||
| Q4 24 | $-16.5M | $9.0M | ||
| Q3 24 | $-2.3M | $244.0K | ||
| Q2 24 | $-2.1M | $-5.2M | ||
| Q1 24 | $7.5M | $774.0K |
毛利率AORTRICK
| Q4 25 | 63.1% | — | ||
| Q3 25 | 65.6% | — | ||
| Q2 25 | 64.7% | — | ||
| Q1 25 | 64.2% | — | ||
| Q4 24 | 63.2% | — | ||
| Q3 24 | 63.7% | — | ||
| Q2 24 | 64.6% | — | ||
| Q1 24 | 64.6% | — |
营业利润率AORTRICK
| Q4 25 | 9.2% | — | ||
| Q3 25 | 11.1% | -0.7% | ||
| Q2 25 | 7.4% | 12.2% | ||
| Q1 25 | 2.2% | 12.4% | ||
| Q4 24 | 2.7% | 19.5% | ||
| Q3 24 | 4.6% | 4.8% | ||
| Q2 24 | 6.6% | -3.3% | ||
| Q1 24 | 26.0% | 6.4% |
净利率AORTRICK
| Q4 25 | 2.1% | — | ||
| Q3 25 | 5.7% | -7.8% | ||
| Q2 25 | 1.2% | 5.7% | ||
| Q1 25 | -0.5% | 4.9% | ||
| Q4 24 | -16.9% | 12.6% | ||
| Q3 24 | -2.4% | 0.3% | ||
| Q2 24 | -2.2% | -6.9% | ||
| Q1 24 | 7.7% | 1.1% |
每股收益（稀释后）AORTRICK
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.13 | $-0.60 | ||
| Q2 25 | $0.03 | $0.46 | ||
| Q1 25 | $-0.01 | $0.36 | ||
| Q4 24 | $-0.40 | $1.01 | ||
| Q3 24 | $-0.05 | $0.04 | ||
| Q2 24 | $-0.05 | $-0.56 | ||
| Q1 24 | $0.18 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.9M | $33.7M |
| 总债务越低越好 | $215.1M | $238.2M |
| 股东权益账面价值 | $448.2M | $261.1M |
| 总资产 | $884.8M | $596.9M |
| 负债/权益比越低杠杆越低 | 0.48× | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资AORTRICK
| Q4 25 | $64.9M | — | ||
| Q3 25 | $73.4M | $33.7M | ||
| Q2 25 | $53.5M | $29.3M | ||
| Q1 25 | $37.7M | $32.7M | ||
| Q4 24 | $53.5M | $34.7M | ||
| Q3 24 | $56.2M | $32.4M | ||
| Q2 24 | $55.0M | $34.9M | ||
| Q1 24 | $51.1M | $20.0M |
总债务AORTRICK
| Q4 25 | $215.1M | — | ||
| Q3 25 | $214.9M | $238.2M | ||
| Q2 25 | $215.6M | $243.8M | ||
| Q1 25 | $314.7M | $244.1M | ||
| Q4 24 | $314.3M | — | ||
| Q3 24 | $314.0M | $241.1M | ||
| Q2 24 | $313.6M | — | ||
| Q1 24 | $313.3M | — |
股东权益AORTRICK
| Q4 25 | $448.2M | — | ||
| Q3 25 | $438.7M | $261.1M | ||
| Q2 25 | $419.9M | $269.5M | ||
| Q1 25 | $294.3M | $268.8M | ||
| Q4 24 | $276.2M | $269.0M | ||
| Q3 24 | $304.7M | $263.4M | ||
| Q2 24 | $295.1M | $271.2M | ||
| Q1 24 | $295.0M | $285.8M |
总资产AORTRICK
| Q4 25 | $884.8M | — | ||
| Q3 25 | $857.7M | $596.9M | ||
| Q2 25 | $838.4M | $597.4M | ||
| Q1 25 | $791.2M | $589.8M | ||
| Q4 24 | $789.1M | $586.2M | ||
| Q3 24 | $803.1M | $584.4M | ||
| Q2 24 | $789.5M | $601.0M | ||
| Q1 24 | $784.0M | $609.9M |
负债/权益比AORTRICK
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.49× | 0.91× | ||
| Q2 25 | 0.51× | 0.90× | ||
| Q1 25 | 1.07× | 0.91× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.03× | 0.92× | ||
| Q2 24 | 1.06× | — | ||
| Q1 24 | 1.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.6M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-7.9M | $11.5M |
| 自由现金流率自由现金流/营收 | -6.9% | 16.2% |
| 资本支出强度资本支出/营收 | 23.7% | 3.2% |
| 现金转化率经营现金流/净利润 | 8.06× | — |
| 过去12个月自由现金流最近4个季度 | $839.0K | $34.9M |
8季度趋势，按日历期对齐
经营现金流AORTRICK
| Q4 25 | $19.6M | — | ||
| Q3 25 | $22.3M | $13.7M | ||
| Q2 25 | $15.0M | $13.8M | ||
| Q1 25 | $-17.0M | $8.5M | ||
| Q4 24 | $10.1M | $13.3M | ||
| Q3 24 | $11.5M | $15.7M | ||
| Q2 24 | $6.1M | $15.8M | ||
| Q1 24 | $-5.5M | $10.8M |
自由现金流AORTRICK
| Q4 25 | $-7.9M | — | ||
| Q3 25 | $17.7M | $11.5M | ||
| Q2 25 | $11.7M | $10.1M | ||
| Q1 25 | $-20.6M | $5.7M | ||
| Q4 24 | $8.7M | $7.6M | ||
| Q3 24 | $7.8M | $10.3M | ||
| Q2 24 | $3.6M | $9.3M | ||
| Q1 24 | $-9.1M | $3.2M |
自由现金流率AORTRICK
| Q4 25 | -6.9% | — | ||
| Q3 25 | 15.6% | 16.2% | ||
| Q2 25 | 10.4% | 14.2% | ||
| Q1 25 | -20.8% | 8.6% | ||
| Q4 24 | 9.0% | 10.6% | ||
| Q3 24 | 8.2% | 14.0% | ||
| Q2 24 | 3.7% | 12.3% | ||
| Q1 24 | -9.3% | 4.4% |
资本支出强度AORTRICK
| Q4 25 | 23.7% | — | ||
| Q3 25 | 4.1% | 3.2% | ||
| Q2 25 | 2.9% | 5.2% | ||
| Q1 25 | 3.7% | 4.3% | ||
| Q4 24 | 1.5% | 8.0% | ||
| Q3 24 | 3.8% | 7.3% | ||
| Q2 24 | 2.6% | 8.4% | ||
| Q1 24 | 3.7% | 10.6% |
现金转化率AORTRICK
| Q4 25 | 8.06× | — | ||
| Q3 25 | 3.42× | — | ||
| Q2 25 | 11.16× | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.73× | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AORT
| Aortic Stent Grafts | $43.3M | 37% |
| On X | $27.8M | 24% |
| Preservation Services | $24.1M | 21% |
| Surgical Sealants | $20.3M | 18% |
| Other Products | $463.0K | 0% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
